Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | NBBK | CFFN |
|---|---|---|
| Price | $22.27 | $8.42 |
| Change today | ▼ 0.85% | ▼ 1.17% |
| Market cap | $975.84M | $1.06B |
| Return, 3 months | +6.3% | +0.2% |
| Return, year to date | +13.4% | +28.4% |
| Return, 1 year | +29.1% | +40.7% |
| P/E (TTM) | 14.7 | 13.0 |
| P/B | 1.2 | 1.0 |
| P/E percentile vs own 5y | 27th | 38th |
| Dividend yield | 1.26% | 4.04% |
| Revenue growth (YoY, latest qtr) | +45.7% | +19.0% |
| Net profit growth (YoY) | +44.9% | +28.2% |
| Gross margin | – | – |
| Operating margin | – | – |
| Net margin | 22.8% | 36.5% |
| Return on equity | 7.5% | 8.0% |
| Analyst target vs. price | +14.5% | +9.9% |
| Analyst buy share | 50% | 0% |
| RSI (14) | 45 | 40 |
| 30-day volatility | 14.2% | 17.1% |
| Max drawdown, 1 year | -15.4% | -10.6% |
| Trend read | Leaning bearish | Leaning bearish |
| Analyst consensus | Buy | Hold |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
